Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HOTTIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CHML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FBLN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NT5DC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THEM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM204A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCNP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNTFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNAPC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOCK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLTC-IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4E2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on